Stefan Bernstein explains how the EU/Greenland critical raw materials partnership benefits GreenRoc. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE
Stefan Bernstein explains how the EU/Greenland critical raw materials partnership benefits GreenRoc
Stefan Bernstein explains how the EU/Greenland critical raw materials partnership benefits GreenRocView Video
Utilico Insights - Jacqueline Broers assesses why Vietnam could be the darling of Asia for investors
Utilico Insights - Jacqueline Broers assesses why Vietnam could be the darling of Asia for investorsView Video

Latest Share Chat

Oxford Biomedica jumps after AstraZeneca orders more Covid-19 vaccines

Tue, 18th May 2021 11:52

(Alliance News) - Oxford Biomedica PLC on Tuesday raised its revenue and profit guidance after AstraZeneca PLC committed to buy more Covid-19 vaccines than previously agreed in the second half of 2021.

Shares in Oxford Biomedica were up 12% to 1,120.00 pence in London, the top performer in the FTSE 250 index on Tuesday. AstraZeneca was up 0.5% to 7,930.55p.

The two companies signed an 18-month supply deal in September under a three-year master supply and development agreement, in which Oxford Biomedica manufactures the vaccine developed by AstraZeneca and the University of Oxford.

Oxford Biomedica now expects cumulative revenue from AstraZeneca by the end of this year of more than GBP100 million, up from the previous guidance of more than GBP50 million.

As a result, there should be "significant growth" in operating earnings before interest, tax, depreciation and amortisation this year, the gene and cell therapy company said.

By Ivan Edwards; ivanedwards@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

Related Shares

More News
27 Mar 2024 12:02

LONDON MARKET MIDDAY: FTSE 100 underperforms ahead of US PCE data

(Alliance News) - Stock prices in London were lower at midday on Wednesday, but trade was more confident in mainland Europe, with focus turning to the...

27 Mar 2024 11:56

C4X Discovery seeks AIM delisting but half-year revenue skyrockets

(Alliance News) - C4X Discovery Holdings PLC shares plunged on Wednesday after it said it plans to delist from AIM in London, due to "the recent downt...

27 Mar 2024 09:19

AstraZeneca treatments become "first and only" to be approved in Japan

(Alliance News) - AstraZeneca PLC announced on Wednesday the approval of two of its treatments for use in Japan.

27 Mar 2024 09:03

LONDON MARKET OPEN: FTSE 100 slips as unease lingers before US data

(Alliance News) - Stock prices in London edged lower after the open on Wednesday, with some nervy trade ahead of a US inflation reading later in the w...

27 Mar 2024 08:02

LONDON BRIEFING: Diploma makes buy; Astra wins Japan drug approvals

(Alliance News) - Stocks in London opened in a muted fashion on Wednesday, with some unease lingering in equity markets ahead of a US inflation readin...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.